PTGS2 and neoplasm: Not only is COX-2 expression remarkably higher in malignant tumours than normal tissues, it is also found to be higher in larger tumours (≥ 5cm), and in tumours with increased depth of invasion (up to the serosa), poorer differentiation, advanced stage of disease (Duke stage C and D) and distant metastasis [6].